Assessment of Pharmacotherapy and Clinical Outcomes of Treatment for the Development of Cardiovascular Disease among Tuberculosis Patients

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Tuberculosis (TB) continues to impose a substantial morbidity and mortality burden globally, particularly in developing countries. Growing evidence suggests an epidemiological and pathological interplay between TB and cardiovascular disease (CVD). Beyond conventional cardiovascular risk factors such as diabetes mellitus, hypertension, and dyslipidemia, there...

Topics

Open a Topic to create a Post that cites this publication.

• Drug-Induced Hepatotoxicity and Protection
• Infectious Diseases and Tuberculosis
• Liver Disease Diagnosis and Treatment
• Mycobacterium research and diagnosis
• Pharmacogenetics and Drug Metabolism
• Tuberculosis Research and Epidemiology

Identifiers and source

Literature Corpus work

6719ba60-46a6-526c-a34b-0836db5ae623

DOI

10.21203/rs.3.rs-8338608/v1